Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

5-HT2B/2C antagonists disclosed by SKB

Oct. 4, 1996

Novel benzodiazepine derivatives from Roche

Oct. 4, 1996

Merck & Co. reports 5-HT1Dalpha receptor agonists

Oct. 4, 1996

Janssen describes vasoconstrictors for migraine Rx

Oct. 4, 1996

Potential of cannabinoid derivative in pain and inflammation

Oct. 4, 1996

Tachykinin antagonists disclosed by Sanofi

Oct. 4, 1996

Glaxo Wellcome prepares a novel class of glycine-site NMDA receptor antagonists

Sep. 27, 1996

Yamanouchi describes AMPA antagonists for stroke

Sep. 27, 1996

Sagami prepares NGF production-enhancing compounds

Sep. 27, 1996

Natural cerebral function-improving agents from Yamanouchi

Sep. 27, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...